Retraction: miR-211 suppresses hepatocellular carcinoma by downregulating SATB2.
APA
Jiang G, Cui Y, et al. (2026). Retraction: miR-211 suppresses hepatocellular carcinoma by downregulating SATB2.. Oncotarget, 17(1), 199-200. https://doi.org/10.18632/oncotarget.28837
MLA
Jiang G, et al.. "Retraction: miR-211 suppresses hepatocellular carcinoma by downregulating SATB2.." Oncotarget, vol. 17, no. 1, 2026, pp. 199-200.
PMID
42030541
같은 제1저자의 인용 많은 논문 (5)
- Research progress on the characteristics and functions of m6A modification in lung cancer tumor stem cells.
- Development and validation of machine learning models for diagnosing hepatocellular carcinoma risk and survival in patients with diabetic cirrhosis.
- Modified Shenlingbaizhu decoction suppresses colon cancer via enhancing memory-like Tfh differentiation and B cell responses.
- Cetylpyridinium chloride inhibits the polarization of tumor-associated macrophages and the proliferation of triple-negative breast cancer cells.
- Unraveling the prognostic significance and molecular mechanisms of HKDC1 in cancer via integrated multi-omics and experimental validation.